Sign Up to like & get
recommendations!
1
Published in 2017 at "Acta Physiologica"
DOI: 10.1111/apha.12632
Abstract: Extracellular signal‐regulated kinase (ERK) 1/2 is activated during acute phase of stroke and contributes to stroke pathology. We have found that acute treatment with MEK1/2 inhibitors decreases infarct size and neurological deficits 2 days after…
read more here.
Keywords:
acute phase;
term;
long term;
kinase ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Stroke"
DOI: 10.1161/strokeaha.116.016433
Abstract: Background and Purpose— Treatments that improve function in late phase after stroke are urgently needed. We assessed whether multimodal interventions based on rhythm-and-music therapy or horse-riding therapy could lead to increased perceived recovery and functional…
read more here.
Keywords:
rhythm music;
music therapy;
phase stroke;
therapy ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Diabetes"
DOI: 10.2337/db20-0095
Abstract: The interplay between obesity and type 2 diabetes (T2D) in poststroke recovery is unclear. Moreover, the impact of glucose control during the chronic phase after stroke is undetermined. We investigated whether obesity-induced T2D impairs neurological…
read more here.
Keywords:
recovery;
neurological recovery;
phase stroke;
type diabetes ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "NeuroRehabilitation"
DOI: 10.3233/nre-203024
Abstract: BACKGROUND Few patients with severe upper extremity (UE) paresis after stroke achieved full recovery, because of the lack of a definitive approach to improve severe UE paresis immediately after onset. OBJECTIVE to investigate the effects…
read more here.
Keywords:
acute phase;
coupled emg;
phase stroke;
early acute ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms232112886
Abstract: Pharmacological agents limiting secondary tissue loss and improving functional outcomes after stroke are still limited. Cannabidiol (CBD), the major non-psychoactive component of Cannabis sativa, has been proposed as a neuroprotective agent against experimental cerebral ischemia.…
read more here.
Keywords:
balancing effect;
phase stroke;
ischemia;
subacute phase ... See more keywords